IL-31-IL-31R interactions limit the magnitude of Th2 cytokine-dependent immunity and inflammation following intestinal helminth infection

Journal of Immunology

Volumn 182, Issue 10, 2009, Pages 6088-6094

  Perrigoue, Jacqueline G ^a   Zaph, Colby ^b   Guild, Katherine ^a   Du, Yurong ^a   Artis, David ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 31; INTERLEUKIN 31 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN RECEPTOR; MESSENGER RNA; RESISTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL HYPERPLASIA; COLON; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENTERITIS; GENE EXPRESSION; GOBLET CELL; HELMINTHIASIS; IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; TRICHURIS; WILD TYPE;

ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL PROLIFERATION; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GOBLET CELLS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKINS; INTESTINAL DISEASES, PARASITIC; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH2 CELLS; TRICHURIASIS;

EID: 73449096297     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802459     Document Type: Article

References (39)

1. Boulay, J. L., J. J. O'Shea, and W. E. Paul. 2003. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity 19: 159-163.
2. Ghilardi, N., J. Li, J. A. Hongo, S. Yi, A. Gurney, and F. J. de Sauvage. 2002. A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5. J. Biol. Chem. 277: 16831-16836. (Pubitemid 34967706)
3. Muller-Newen, G. 2003. The cytokine receptor gp130: faithfully promiscuous. Sci STKE 2003: PE40.
4. Diveu, C., E. Lelievre, D. Perret, A. H. Lak-Hal, J. Froger, C. Guillet, S. Chevalier, F. Rousseau, A. Wesa, L. Preisser, et al. 2003. GPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptor. J. Biol. Chem. 278: 49850-49859. (Pubitemid 37548819)
5. Dreuw, A., S. Radtke, S. Pflanz, B. E. Lippok, P. C. Heinrich, and H. M. Hermanns. 2004. Characterization of the signaling capacities of the novel gp130-like cytokine receptor. J. Biol. Chem. 279: 36112-36120. (Pubitemid 39100619)
6. Dillon, S. R., C. Sprecher, A. Hammond, J. Bilsborough, M. Rosenfeld-Franklin, S. R. Presnell, H. S. Haugen, M. Maurer, B. Harder, J. Johnston, et al. 2004. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 5: 752-760.
7. Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5: 521-531.
8. Batten, M., and N. Ghilardi. 2007. The biology and therapeutic potential of interleukin 27. J Mol. Med. 85: 661-672.
9. Nishimoto, N., and T. Kishimoto. 2004. Inhibition of IL-6 for the treatment of inflammatory diseases. Curr. Opin. Pharmacol. 4: 386-391. (Pubitemid 38987066)
10. Ip, W. K., C. K. Wong, M. L. Li, P. W. Li, P. F. Cheung, and C. W. Lam. 2007. Interleukin-31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen-activated protein kinase signalling pathways: implications for the allergic response. Immunology 122: 532-541.
11. Chattopadhyay, S., E. Tracy, P. Liang, O. Robledo, S. Rose-John, and H. Baumann. 2007. Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells. J. Biol. Chem. 282: 3014-3026. (Pubitemid 47084348)
12. Bilsborough, J., D. Y. Leung, M. Maurer, M. Howell, M. Boguniewcz, L. Yao, H. Storey, C. LeCiel, B. Harder, and J. A. Gross. 2006. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J. Allergy Clin. Immunol. 117: 418-425. (Pubitemid 43190155)
13. Neis, M. M., B. Peters, A. Dreuw, J. Wenzel, T. Bieber, C. Mauch, T. Krieg, S. Stanzel, P. C. Heinrich, H. F. Merk, et al. 2006. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J. Allergy Clin. Immunol. 118: 930-937.
14. Sonkoly, E., A. Muller, A. I. Lauerma, A. Pivarcsi, H. Soto, L. Kemeny, H. Alenius, M. C. Dieu-Nosjean, S. Meller, J. Rieker, et al. 2006. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J. Allergy Clin. Immunol. 117: 411-417. (Pubitemid 43192023)
15. Takaoka, A., I. Arai, M. Sugimoto, Y. Honma, N. Futaki, A. Nakamura, and S. Nakaike. 2006. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Exp. Dermatol. 15: 161-167.
16. Takaoka, A., I. Arai, M. Sugimoto, A. Yamaguchi, M. Tanaka, and S. Nakaike. 2005. Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. Eur. J. Pharmacol. 516: 180-181. (Pubitemid 40799355)
17. Perrigoue, J. G., J. Li, C. Zaph, M. Goldschmidt, P. Scott, F. J. de Sauvage, E. J. Pearce, N. Ghilardi, and D. Artis. 2007. IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung. J. Exp. Med. 204: 481-487.
18. Cliffe, L. J., and R. K. Grencis. 2004. The Trichuris muris system: a paradigm of resistance and susceptibility to intestinal nematode infection. Adv. Parasitol. 57: 255-307.
19. Artis, D., A. Villarino, M. Silverman, W. He, E. M. Thornton, S. Mu, S. Summer, T. M. Covey, E. Huang, H. Yoshida, et al. 2004. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173: 5626-5634. (Pubitemid 39392150)
20. Harless, S. M., V. M. Lentz, A. P. Sah, B. L. Hsu, K. Clise-Dwyer, D. M. Hilbert, C. E. Hayes, and M. P. Cancro. 2001. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Curr. Biol. 11: 1986-1989.
21. Bancroft, A. J., A. N. McKenzie, and R. K. Grencis. 1998. A critical role for IL-13 in resistance to intestinal nematode infection. J. Immunol. 160: 3453-3461.
22. Artis, D., M. L. Wang, S. A. Keilbaugh, W. He, M. Brenes, G. P. Swain, P. A. Knight, D. D. Donaldson, M. A. Lazar, H. R. Miller, et al. 2004. RELMβ/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc. Natl. Acad. Sci. USA 101: 13596-13600. (Pubitemid 39238448)
23. Owyang, A. M., C. Zaph, E. H. Wilson, K. J. Guild, T. McClanahan, H. R. Miller, D. J. Cua, M. Goldschmidt, C. A. Hunter, R. A. Kastelein, and D. Artis. 2006. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J. Exp. Med. 203: 843-849.
24. Artis, D., S. Shapira, N. Mason, K. M. Speirs, M. Goldschmidt, J. Caamano, H. C. Liou, C. A. Hunter, and P. Scott. 2002. Differential requirement for NF-κB family members in control of helminth infection and intestinal inflammation. J. Immunol. 169: 4481-4487. (Pubitemid 35178225)
25. + T cells to produce IL-4. J. Immunol. 158: 4171-4179.
26. Linton, P. J., B. Bautista, E. Biederman, E. S. Bradley, J. Harbertson, R. M. Kondrack, R. C. Padrick, and L. M. Bradley. 2003. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J. Exp. Med. 197: 875-883.
27. Stockinger, B., T. Zal, A. Zal, and D. Gray. 1996. B cells solicit their own help from T cells. J. Exp. Med. 183: 891-899. (Pubitemid 26113961)
28. Cliffe, L. J., N. E. Humphreys, T. E. Lane, C. S. Potten, C. Booth, and R. K. Grencis. 2005. Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science 308: 1463-1465.
29. Nair, M. G., K. J. Guild, and D. Artis. 2006. Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy. J. Immunol. 177: 1393-1399.
30. Zaph, C., A. E. Troy, B. C. Taylor, L. D. Berman-Booty, K. J. Guild, Y. Du, E. A. Yost, A. D. Gruber, M. J. May, F. R. Greten, et al. 2007. Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis. Nature 446: 552-556. (Pubitemid 46514719)
31. Artis, D., and R. Grencis. 2008. The intestinal epithelium: sensors to effectors in nematode infection. Mucosal Immunol. 1: 252-264. (Pubitemid 351850532)
32. Chen, S. H., and E. N. Benveniste. 2004. Oncostatin M: a pleiotropic cytokine in the central nervous system. Cytokine Growth Factor Rev. 15: 379-391. (Pubitemid 39144383)
33. Akira, S. 2000. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene 19: 2607-2611. (Pubitemid 30339216)
34. Artis, D., L. M. Johnson, K. Joyce, C. Saris, A. Villarino, C. A. Hunter, and P. Scott. 2004. Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection. J. Immunol. 172: 4672-4675. (Pubitemid 38456385)
35. Yoshida, H., S. Hamano, G. Senaldi, T. Covey, R. Faggioni, S. Mu, M. Xia, A. C. Wakeham, H. Nishina, J. Potter, et al. 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15: 569-578. (Pubitemid 33016442)
36. Stumhofer, J. S., A. Laurence, E. H. Wilson, E. Huang, C. M. Tato, L. M. Johnson, A. V. Villarino, Q. Huang, A. Yoshimura, D. Sehy, et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7: 937-945.
37. Batten, M., J. Li, S. Yi, N. M. Kljavin, D. M. Danilenko, S. Lucas, J. Lee, F. J. de Sauvage, and N. Ghilardi. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7: 929-936. (Pubitemid 44263906)
38. Villarino, A., L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, R. A. Kastelein, C. Saris, and C. A. Hunter. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19: 645-655. (Pubitemid 37490790)
39. Miyazaki, Y., H. Inoue, M. Matsumura, K. Matsumoto, T. Nakano, M. Tsuda, S. Hamano, A. Yoshimura, and H. Yoshida. 2005. Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice. J. Immunol. 175: 2401-2407. (Pubitemid 41113850)